Respiratory syncytial virus (RSV) is a major healthcare concern, especially for immune-
compromised individuals and infants below 5 years of age. Worldwide, it is known to be …

Adjuvants are crucial components of vaccines. They significantly improve vaccine efficacy by
modulating, enhancing, or extending the immune response and at the same time reducing …

Background Porcine epidemic diarrhea virus (PEDV) is a highly contagious virus infecting
pigs of all ages with high morbidity and mortality among newborn piglets. Currently, there is …

Respiratory syncytial virus (RSV) infection accounts for approximately 64 million cases of
respiratory disease and 200,000 deaths worldwide each year, yet no broadly effective …

Structure-based vaccine design has been used to develop immunogens that display
conserved neutralization sites on pathogens such as HIV-1, respiratory syncytial virus …

Adjuvants are vaccine components that can boost the type, magnitude, breadth, and
durability of an immune response. We have previously demonstrated that certain adjuvant …

Polyphosphazenes are a class of experimental adjuvants that have shown great versatility
as vaccine adjuvants in many animal species ranging from laboratory rodents to large …

Abstract Bacillus Calmette-Guerin (BCG) is the only vaccine against TB and has limited
protection efficacy, which wanes past adolescence. Multifunctional CD8+ T cells (IFN …

Adjuvants are crucial components of many vaccines. They are used to improve the
immunogenicity of vaccines with the aim of conferring long-term protection, to enhance the …

Adjuvants are used to improve the immune response to vaccines. Formulation with
adjuvants can result in an earlier onset of immunity, an overall stronger immune response, a …